See the factory by live video walkthrough
Book an on-site factory visit in GuangzhouNiacinamide has become a skincare staple, appearing in everything from daily moisturizers to targeted serums. Yet when it comes to the delicate under-eye area and the persistent problem of dark circles, the ingredient’s real…
Niacinamide has become a skincare staple, appearing in everything from daily moisturizers to targeted serums. Yet when it comes to the delicate under-eye area and the persistent problem of dark circles, the ingredient’s real capabilities are often overstated. For brand owners and formulators, understanding exactly where niacinamide can deliver and where it falls short is essential to building a compliant, effective eye serum—and to avoiding costly claim rejections later.
Niacinamide (vitamin B3) is a multi-tasking ingredient with proven benefits that can help improve the appearance of the under-eye area. Its primary mechanisms include:
However, dark circles have multiple origins. Niacinamide is most effective against pigmented dark circles caused by excess melanin or post-inflammatory hyperpigmentation. For vascular dark circles (visible blue/red blood vessels), it offers only minimal improvement through barrier support; true vasoconstriction requires actives like caffeine or vitamin K oxide. Structural dark circles—tear trough shadows caused by fat loss or bone structure—cannot be corrected by any topical ingredient, including niacinamide.
Setting realistic expectations early protects your brand’s credibility. Here are the non-negotiable limits of niacinamide in an eye serum:
Within cosmetics regulations, the goal is to use carefully crafted performance claims that are both compelling and defensible. Below are claim examples mapped to the evidence typically required for a niacinamide eye serum targeting the under-eye area.
| Permissible Claim | Underpinning Mechanism | Typical Substantiation |
|---|---|---|
| Helps brighten the under-eye area | Melanosome transfer inhibition; improved barrier uniformity | Clinical study with image analysis, chromameter measurements, or VISIA-CR imaging over 8–12 weeks |
| Improves the appearance of dark circles | Reduction in pigmentation and surface roughness | Expert-graded clinical trial with a statistically significant decrease in dark circle severity score |
| Visibly reduces the look of puffiness | Anti-inflammatory and barrier-strengthening effects; often amplified with caffeine | Instrumental measurement (e.g. fringe projection for under-eye volume) plus consumer perception study |
| Supports the skin’s moisture barrier | Stimulation of ceramide synthesis | TEWL measurement or corneometer data; ingredient-level literature support |
Important: Never bridge into drug territory. Statements like “reduces dark circles” may be acceptable if supported and qualified, but “treats periorbital hyperpigmentation” or “eliminates dark circles” are red flags. Always review your final label copy with a regulatory consultant familiar with your target market.
To address the multiple facets of dark circles, combine niacinamide with carefully selected ingredients:
The under-eye skin is thin and easily irritated. A lightweight, fast-absorbing serum or gel-cream texture performs best. Use an airless opaque pump or dropper to protect light-sensitive actives and maintain product integrity. A cooling metal applicator can enhance the immediate de-puffing sensation—adding a valuable sensory claim.
Niacinamide is stable across a wide pH range, but avoid extremely low pH (below 4.5) to prevent hydrolysis into nicotinic acid, which causes flushing and stinging. In a water-based formula, maintain a pH of 5.0–6.5 and perform accelerated stability testing at 40°C/75% RH for at least 3 months. Compatibility with chelating agents and antioxidants is good, but always run a full preservative efficacy test (PET) due to the delicate application area.
Most well-tolerated eye formulations use 2–4%. This level delivers brightening benefits without excessive risk of irritation. Going to 5% is possible but demands a pristine formulation and thorough sensitization testing.
Yes, and the combination is often used to address both pigmentation and skin thinning. However, retinol around the eyes raises irritation risk significantly. Start with a low-strength retinol ester and ensure the formula is buffered and supported by barrier-repairing ingredients.
In well-designed studies, measurable improvement in periorbital pigmentation is usually observed after 8 weeks, with maximum results at 12–16 weeks. Set consumer expectations accordingly to maintain trust.
Legally, you need “adequate substantiation” for any cosmetic claim. For high-stakes claims like “improves the appearance of dark circles,” a controlled clinical study with a sufficient sample size is strongly recommended. Consumer perception studies alone may not satisfy regulators in markets like the EU or UK.
Any wording that suggests a medical condition (e.g., hyperpigmentation, under-eye bags, periorbital melanosis) can shift your product from a cosmetic to a drug classification. Stick to cosmetic language like “appearance of dark circles” and ensure your evidence matches exactly what you state on the label.
Ready to develop a science-backed niacinamide eye serum that meets your brand’s claims goals? Request a Quote from Laeyo Labs to start your formulation project today.